Rain Oncology

Rain Oncology

Biotechnology, Newark, California, United States, 51-200 Employees

rainoncology.com

  • LinkedIn

phone no Phone Number: 51********

Who is RAIN ONCOLOGY

Rain Oncology is a clinical-stage company researching, developing and translating innovative targeted therapies for patients with cancer to help provide them hope to get their lives back....

Read More

map

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from RAIN ONCOLOGY

Rain Oncology Org Chart and Mapping

Avanish Vellanki

Cofounder, Chairman & CEO

VP-Level

Nelson Cabatuan

SVP Finance and Operations

Employees

Mohammad MSC

Director Drug Product Development

Feng Xu

Vice President, Head of Biometrics

Christine Kwong

Executive Director, Commercial Strategy and Marketing

Sonia Bhullar

Human Resources Coordinator

Mohammad Riaz

Head of Cmc - Drug Product Operations

Sangram Raut

Senior Clinical Scientist

Naisargee Shah

Director, Clinical Science and Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Rain Oncology

Answer: Rain Oncology's headquarters are located at Newark, California, United States

Answer: Rain Oncology's phone number is 51********

Answer: Rain Oncology's official website is https://rainoncology.com

Answer: Rain Oncology's revenue is $10 Million to $25 Million

Answer: Rain Oncology's SIC: 2836

Answer: Rain Oncology's NAICS: 541714

Answer: Rain Oncology has 51-200 employees

Answer: Rain Oncology is in Biotechnology

Answer: Rain Oncology contact info: Phone number: 51******** Website: https://rainoncology.com

Answer: Rain Oncology is a clinical-stage company researching, developing and translating innovative targeted therapies for patients with cancer to help provide them hope to get their lives back. Our therapies target oncogenic drivers to genetically select patients it believes will most likely benefit. This approach includes using a tumor-agnostic strategy to select patients based on their tumors underlying genetics rather than histology.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access